Indaptus Therapeutics (INDP) to Release Earnings on Wednesday

Indaptus Therapeutics (NASDAQ:INDPGet Free Report) will likely be issuing its quarterly earnings data before the market opens on Wednesday, March 12th. Analysts expect the company to announce earnings of ($0.41) per share for the quarter.

Indaptus Therapeutics Stock Performance

Shares of NASDAQ INDP opened at $0.83 on Monday. Indaptus Therapeutics has a 1 year low of $0.70 and a 1 year high of $3.10. The firm has a market cap of $11.65 million, a price-to-earnings ratio of -0.48 and a beta of 1.60. The stock’s 50-day simple moving average is $0.86 and its 200-day simple moving average is $1.10.

Wall Street Analyst Weigh In

Separately, Maxim Group dropped their target price on Indaptus Therapeutics from $8.00 to $5.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th.

Read Our Latest Research Report on INDP

Indaptus Therapeutics Company Profile

(Get Free Report)

Indaptus Therapeutics, Inc, a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, which is in Phase 2 clinical trial.

Featured Stories

Earnings History for Indaptus Therapeutics (NASDAQ:INDP)

Receive News & Ratings for Indaptus Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indaptus Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.